Table 1

Patient and disease characteristics

Surgery onlyNHT (12 weeks)NHT (24 weeks)Total
NHT, neoadjuvant hormonal treatment; PSA, prostate specific antigen.
Patients (n)128143122393
Mean age in years65.7265.4366.16
(range)52–7649–7651–76
Clinical stage B (n)9910891298
Clinical stage C (n)29353195
PSA (ng/ml) median10.2010.1510.0
PSA (ng/ml) range0.8–763.60.0–131.81.4–100.3